Yongfeng F. Yang

Nanjing Key Laboratory Of Hepatology
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Letter: A Histology-Defined Triple-Negative Phenotype of Primary Biliary Cholangitis.

Letter: A Histology-Defined Triple-Negative Phenotype of Primary Biliary Cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: June 03, 2026

Development and progression of hepatic steatosis during long-term glucocorticoid therapy in autoimmune hepatitis: multimodal evidence from biopsy, CAP, and ultrasound.

Development and progression of hepatic steatosis during long-term glucocorticoid therapy in autoimmune hepatitis: multimodal evidence from biopsy, CAP, and ultrasound.

Journal: Frontiers in medicine

Published: May 26, 2026

Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study.

Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real-World Cohort Study.

Journal: Journal of viral hepatitis

Published: May 10, 2026

Esophageal Stenosis Secondary to Sengstaken-Blakemore Tube Malposition.

Esophageal Stenosis Secondary to Sengstaken-Blakemore Tube Malposition.

Journal: The American journal of gastroenterology

Published: May 05, 2026

Referral-spectrum Effect in Hypercupriuric Referrals for Suspected Wilson Disease: Diagnostic Implications for Ceruloplasmin and 24-hour Urinary Copper Excretion.

Referral-spectrum Effect in Hypercupriuric Referrals for Suspected Wilson Disease: Diagnostic Implications for Ceruloplasmin and 24-hour Urinary Copper Excretion.

Journal: Journal of clinical and translational hepatology

Published: April 12, 2026

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Journal: Clinical reviews in allergy & immunology

Published: March 03, 2026

Inflammatory mediators are predictors of clinical outcomes in cirrhotic patients with non-acute decompensation.

Inflammatory mediators are predictors of clinical outcomes in cirrhotic patients with non-acute decompensation.

Journal: BMC gastroenterology

Published: January 23, 2026

Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study.

Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study.

Journal: Journal of gastroenterology and hepatology

Published: December 20, 2025

A Rare Etiology of Hepatic Steatosis.

A Rare Etiology of Hepatic Steatosis.

Journal: Gastroenterology

Published: October 14, 2025

Purvalanol A Exerts Anti-Hepatocellular Carcinoma Activity by Activating the p53 Pathway.

Purvalanol A Exerts Anti-Hepatocellular Carcinoma Activity by Activating the p53 Pathway.

Journal: Molecular carcinogenesis

Published: September 17, 2025

Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).

Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).

Journal: Journal of clinical and translational hepatology

Published: August 26, 2025

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China.

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China.

Journal: Journal of clinical and translational hepatology

Published: August 26, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026